Elimination of Liposomes by Different Separation Principles Used in Low‐density Lipoprotein Apheresis
Authors:
- 1 February 2008
- journal article
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 12 (1) , 2-12
Abstract
Abstract: Clinical success of many therapies is impaired by dose limiting toxicities. Nanoscale particle‐based drug delivery systems such as liposomes show unique pharmacokinetic properties and improved toxicity profiles. Liposomes accumulate in tumor tissue, but only a small fraction of a total dose reaches the target site. The overwhelming amount of a given dose is needed only to build up a diffusion gradient for effective accumulation at the target site. In order to find a way to detoxify this predominant fraction after accumulation is completed, the different separation principles used for the apheresis of lipoproteins were evaluated for the extracorporeal elimination of liposomes. Appropriate radiolabeled model liposomes were prepared by extrusion. Separation efficacy, leakage of liposomal content and influence of plasma contact were measured. Membranes with pore sizes between 25 and 400 nm were used to investigate filtration properties of liposomes. Liposomes were precipitated by adding heparin and Ca2+. Adsorption chromatography was investigated using dextran sulfate, heparin sepharose and functionalized polyacrylamide beads. Membrane filtration allowed the elimination of various liposomes, while precipitation and adsorption were only useful for positively charged liposomes. Leakage of liposomal content was not induced by adsorption, but precipitation induced leakage. Leakage during filtration was dependent on liposomal membrane lipids. Plasma contact reduced precipitation and adsorption efficacy of positively charged liposomes, while filtration properties of liposomes remained unchanged. For extracorporeal elimination of liposomal drug delivery systems, filtration‐based techniques are presumably more convenient and versatile than precipitation‐ or adsorption‐based apheresis technologies.Keywords
This publication has 27 references indexed in Scilit:
- Therapeutic Apheresis—State of the Art in the Year 2005Therapeutic Apheresis and Dialysis, 2005
- Synthesis of phospholipid-conjugated bile salts and interaction of bile salt-coated liposomes with cultured hepatocytesJournal of Lipid Research, 2005
- Stabilized plasmid–lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expressionBiochimica et Biophysica Acta (BBA) - Biomembranes, 2005
- Drug Delivery Systems: Entering the MainstreamScience, 2004
- Pharmacokinetics of Pegylated Liposomal DoxorubicinClinical Pharmacokinetics, 2003
- DALI—the first human whole‐blood low‐density lipoprotein and lipoprotein (a) apheresis system in clinical use: procedure and clinical resultsEuropean Journal of Clinical Investigation, 1998
- Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's SarcomaThe Journal of Clinical Pharmacology, 1996
- Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potentialBiochimica et Biophysica Acta (BBA) - Biomembranes, 1985
- Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteinsBiochimica et Biophysica Acta (BBA) - General Subjects, 1978
- Phospholipid model membranes. II. Permeability properties of hydrated liquid crystalsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1967